New FDA Authorization for the BinaxNow Covid-19 Ag Card Home Test
Abbott and eMed expect to deliver and administer 30 million BinaxNow tests in the first quarter of 2021, with an additional 90 million in the second quarter.
Read MorePosted by Laurie Bonner | Dec 16, 2020 | Covid 19, POC Rapid Assays |
Abbott and eMed expect to deliver and administer 30 million BinaxNow tests in the first quarter of 2021, with an additional 90 million in the second quarter.
Read MorePosted by Laurie Bonner | Dec 16, 2020 | Covid 19, Immunoassay Reagents & test Kits |
SARS-CoV-2 IgG II Quant antibody test specifically identifies levels of IgG antibodies that attach to the virus’ spike protein, which can be helpful to evaluate a person’s immune response to vaccines.
Read MorePosted by Laurie Bonner | Dec 16, 2020 | Covid 19, Immunoassay |
Using optical biosensor technology, researchers made quantitative measurements of SARS-CoV-2 antibodies in blood plasma in less than 20 minutes.
Read MorePosted by Melanie Hamilton-Basich | Dec 15, 2020 | Covid 19, Flu & Respiratory Infections |
The new EuroRealTime test allows fast detection and differentiation of genetic material from SARS-CoV-2, influenza virus type A, and influenza virus type B using throat swab samples of patients with acute symptoms.
Read MorePosted by Melanie Hamilton-Basich | Dec 15, 2020 | Lab Automation |
“Thanks to this study, we now have concrete evidence showing that labs, from large to small and from those handling a few hundred bacterial cultures a day to thousands, can all benefit by converting to a fully automated site,” says Copan Scientific Director Susan Sharp.
Read More